Novartis Cosentyx® PMR data in New England Journal of Medicine showed sustained remission vs placebo in twice as many patients Novartis (Press Release) 16:38 Wed, 03 Jun
Celltrion files for approval of Cosentyx biosimilar, CT-P55, in Canada Korea Biomedical Review 07:57 Mon, 01 Jun
ASCO: Novartis To Face Challengers In Growing Radiopharmaceutical Space Scrip Pharma Intelligence 6d Pharma
Positive Del-brax biomarker data offers early support for Novartis’s Avidity bet Scrip Pharma Intelligence 6d Pharma
Novartis to highlight Rhapsido® data across multiple immune-mediated diseases at EAACI Congress 2026 Novartis (Press Release) 08:53 Mon, 08 Jun
Novartis $12bn bet on Avidity well placed after mid-stage FSHD win Clinical Trials Arena 6d Pharma Biotech
